BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26275245)

  • 1. Matrix metalloproteinase 7 expression in ampullary carcinoma.
    Kumari N; Singh RK; Krishnani N; Shukla P
    Indian J Pathol Microbiol; 2015; 58(3):274-8. PubMed ID: 26275245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 5. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
    Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
    Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
    Xue Y; Vanoli A; Balci S; Reid MM; Saka B; Bagci P; Memis B; Choi H; Ohike N; Tajiri T; Muraki T; Quigley B; El-Rayes BF; Shaib W; Kooby D; Sarmiento J; Maithel SK; Knight JH; Goodman M; Krasinskas AM; Adsay V
    Mod Pathol; 2017 Feb; 30(2):255-266. PubMed ID: 27739441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential features of pancreatobiliary- and intestinal-type ampullary carcinomas at MR imaging.
    Chung YE; Kim MJ; Park MS; Choi JY; Kim H; Kim SK; Lee M; Kim HJ; Choi JS; Song SY; Kim KW
    Radiology; 2010 Nov; 257(2):384-93. PubMed ID: 20829529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.
    Kawabata Y; Tanaka T; Nishisaka T; Inao T; Nishi T; Yano S
    Diagn Pathol; 2010 Nov; 5():75. PubMed ID: 21106111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
    Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
    Ang DC; Shia J; Tang LH; Katabi N; Klimstra DS
    Am J Surg Pathol; 2014 Oct; 38(10):1371-9. PubMed ID: 24832159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the location and the histomorphological/immunohistochemical characteristics of noninvasive neoplasms of the ampulla of Vater.
    Yamamoto Y; Nemoto T; Okubo Y; Nihonyanagi Y; Ishiwatari T; Takuma K; Tochigi N; Okano N; Wakayama M; Igarashi Y; Shibuya K
    Hum Pathol; 2014 Sep; 45(9):1910-7. PubMed ID: 25081540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
    Morini S; Perrone G; Borzomati D; Vincenzi B; Rabitti C; Righi D; Castri F; Manazza AD; Santini D; Tonini G; Coppola R; Onetti Muda A
    Pancreas; 2013 Jan; 42(1):60-6. PubMed ID: 22889982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic Intraepithelial Neoplasia (PanIN) as a Morphologic Marker of Pancreatobiliary Type of Ampullary Carcinoma.
    Krishnamurthy K; Sriganeshan V
    Pathol Oncol Res; 2020 Jul; 26(3):1735-1739. PubMed ID: 31642034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
    Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
    J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance.
    Liu F; Shen D; Ma Y; Song Q; Wang H
    J Surg Oncol; 2019 Mar; 119(3):295-302. PubMed ID: 30548547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Study of Carcinoma of the Ampulla of Vater with Special Reference to MUC1, MUC2 and MUC5AC Expression.
    Kulkarni MM; Khandeparkar SGS; Joshi AR; Kakade A; Fegade L; Narkhede K
    J Clin Diagn Res; 2017 May; 11(5):EC17-EC20. PubMed ID: 28658766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.
    Reid MD; Balci S; Ohike N; Xue Y; Kim GE; Tajiri T; Memis B; Coban I; Dolgun A; Krasinskas AM; Basturk O; Kooby DA; Sarmiento JM; Maithel SK; El-Rayes BF; Adsay V
    Mod Pathol; 2016 Dec; 29(12):1575-1585. PubMed ID: 27586202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
    Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
    BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.